Silicone Gel-Filled Breast Implant Market Expectation Surges with Rising Demand and Changing Trends | Allergan plc, Mentor Worldwide LLC

Posted on 2021-03-11 by Future Market Insights, Inc in Healthcare // 0 Comments

Silicone gel-filled breast implants have been approved by the US Food & Drug Administration for breast augmentation among women aged over 22 years. Breast reconstruction is also a lucrative area where silicone gel-filled breast implants seek significant demand, along with their use in the revision surgeries that rectify or improve results of the original surgery. Silicone gel-filled breast implants market is expected to witness bullish prospects as these are not lifetime devices and are associated with periodic replacements.

However, frequent complications experience by patients with silicone gel-filled breast implants, including infection, pain, scarring, asymmetry, wrinkling, and implant rupture, along with capsular contracture and reoperation continue to ebb growth of the silicone gel-filled breast implant market. Much attention has been focused on silicone gel-filled breast implants in recent years, with concerns regarding silicone leak into bodies of these implant recipients.

For detailed insights on enhancing your product footprint, request for a sample here@ https://www.factmr.com/connectus/sample?flag=S&rep_id=875

MRI prevails as an effective silent rupture detection method in patients with silicone gel-filled breast implants. Palpability of MRI in the silicone gel-filled breast implant market is complemented by the FDA’s recommendation for MRI screening post-three years of receiving the implant. Although no direct association has been observed between silicone gel-filled breast implants and tissue diseases, reproductive problems, and breast cancer, more research is required for definitively ruling out concerns of these complications.

Silicone gel-filled breast implants consist of an outer shell made of silicone and filled with silicone gel. The silicone gel is a bit more like natural breast tissue. Silicone gel-filled breast implants are available in different sizes with smooth or textured shells. Generally, silicone gel-filled breast implants are approved for breast augmentation and breast reconstruction surgeries. FDA-approved silicone gel-filled breast implant is for breast augmentation in women aged 22 or older and for breast reconstruction in women of any age. Moreover, the implants are also used in revision surgeries which improve or correct the result of an original surgery. Usually, breast implants are not lifetime devices. Adverse and frequent complications experienced by breast implant patients include reoperation, capsular contracture, and implant removal. Some of the other complications include wrinkling, implant rupture, asymmetry, pain, scarring, and infection. Breast implantation surgery increases the probability of being diagnosed with anaplastic large cell lymphoma (ALCL). MRI is considered to be an effective method for detecting silent rupture of silicone gel-filled breast implants.

To receive extensive list of important regions, ask for TOC here@ https://www.factmr.com/connectus/sample?flag=T&rep_id=875

According to FDA, there are five silicone gel-filled breast implants been approved, namely Allergan Natrelle (approved in November 2006), Allergan Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants (approved in February 2013), Mentor MemoryGel (approved in November 2006), Mentor MemoryShape (approved in June 2013) and Sientra’s Silicone Gel Breast Implants (approved in March 2012).

The growth of the global silicone gel-filled breast implant market is driven by increasing prevalence and incidence of breast cancer in the global population. For instance, according to the research conducted in 2017, it is estimated that 1 in every 8 (nearly 12%) women will develop invasive breast cancer over the course of the lifetime in the U.S. alone. Furthermore, population drifting towards aesthetic appearance and increasing disposable income are also driving the growth of the global silicone gel-filled breast implant market. However, the high cost related to breast implantation surgeries and lack of skilled personnel are the major factors hampering the growth of the global silicone gel-filled breast implant market. Most of the cases of breast implants cause health problems as women with implants need additional surgeries to replace or remove their implant. This hampers the growth of the silicone gel-filled breast implant market. In addition, it is also estimated that one in four women who get breast implants will require additional surgery. The cost of removing or replacing breast implants can be higher than the cost of getting implants in the first place.

Pre-Book Right Now for Exclusive Analyst Support @ https://www.factmr.com/checkout/875/S

The global market for silicone-gel filled breast implant is segmented on basis of application, end user and geography.

Segmentation by Application
- Breast Augmentation
- Breast Reconstruction
Segmentation by End User
- Hospitals
- Clinics
- Cosmetic Clinics
- Ambulatory Surgical Centers

Examples of some of the key players present in the global silicone gel-filled breast implant market are Allergan plc, Mentor Worldwide LLC, Sientra, Inc. and others.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner.

Matched content

Editor’s pick